IHH Healthcare Is Poised for Record-Breaking Revenue -- Market Talk

Dow Jones

2024-09-30

0128 GMT - IHH Healthcare looks set for record-breaking revenue this year, supported by its organic and inorganic growth strategy, Malaysia's visa-free entry for Chinese tourists as well as inelastic demand for healthcare services, RHB IB analyst Oong Chun Sung says in a note. Recent news of potential corporate restructuring to strengthen major shareholders' holding has renewed investor interest, especially as the stock has been trading below its historical valuation average, he says. However, with over 75% of IHH's revenue from Turkey, Singapore and India's operations, the company faces FX risk given the stronger ringgit, with a 5% currency variance potentially impacting net profit by 0.3%-3.7%, he says. RHB raises IHH's target price to MYR8.80 from MYR8.00, while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR7.15.(yingxian.wong@wsj.com)

(END) Dow Jones Newswires

September 29, 2024 21:28 ET (01:28 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2471183078"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2471183078\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2471183078?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-30 09:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2471183078","market":"other","top_or_hot":-1,"title":"IHH Healthcare Is Poised for Record-Breaking Revenue -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0128 GMT - IHH Healthcare looks set for record-breaking revenue this year, supported by its organic and inorganic growth strategy, Malaysia's visa-free entry for Chinese tourists as well as inelastic demand for healthcare services, RHB IB analyst Oong Chun Sung says in a note. Recent news of potential corporate restructuring to strengthen major shareholders' holding has renewed investor interest, especially as the stock has been trading below its historical valuation average, he says. However, with over 75% of IHH's revenue from Turkey, Singapore and India's operations, the company faces FX risk given the stronger ringgit, with a 5% currency variance potentially impacting net profit by 0.3%-3.7%, he says. RHB raises IHH's target price to MYR8.80 from MYR8.00, while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR7.15.(yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 29, 2024 21:28 ET (01:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare Is Poised for Record-Breaking Revenue -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare Is Poised for Record-Breaking Revenue -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-09-30 09:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0128 GMT - IHH Healthcare looks set for record-breaking revenue this year, supported by its organic and inorganic growth strategy, Malaysia's visa-free entry for Chinese tourists as well as inelastic demand for healthcare services, RHB IB analyst Oong Chun Sung says in a note. Recent news of potential corporate restructuring to strengthen major shareholders' holding has renewed investor interest, especially as the stock has been trading below its historical valuation average, he says. However, with over 75% of IHH's revenue from Turkey, Singapore and India's operations, the company faces FX risk given the stronger ringgit, with a 5% currency variance potentially impacting net profit by 0.3%-3.7%, he says. RHB raises IHH's target price to MYR8.80 from MYR8.00, while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR7.15.(yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 29, 2024 21:28 ET (01:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"Q0F.SI","symbol_name":"IHH医疗保健集团","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2471183078","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2471183078","pubTimestamp":1727659680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0128 GMT - IHH Healthcare looks set for record-breaking revenue this year, supported by its organic and inorganic growth strategy, Malaysia's visa-free entry for Chinese tourists as well as inelastic demand for healthcare services, RHB IB analyst Oong Chun Sung says in a note. Recent news of potential corporate restructuring to strengthen major shareholders' holding has renewed investor interest, especially as the stock has been trading below its historical valuation average, he says. However, with over 75% of IHH's revenue from Turkey, Singapore and India's operations, the company faces FX risk given the stronger ringgit, with a 5% currency variance potentially impacting net profit by 0.3%-3.7%, he says. RHB raises IHH's target price to MYR8.80 from MYR8.00, while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR7.15.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"Q0F.SI":"IHH医疗保健集团","HCSG":"医疗保健服务"},"translate_title":"IHH Healthcare有望实现创纪录的收入——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1,"Q0F.SI":0.9},"content_text":"0128 GMT - IHH Healthcare looks set for record-breaking revenue this year, supported by its organic and inorganic growth strategy, Malaysia's visa-free entry for Chinese tourists as well as inelastic demand for healthcare services, RHB IB analyst Oong Chun Sung says in a note. Recent news of potential corporate restructuring to strengthen major shareholders' holding has renewed investor interest, especially as the stock has been trading below its historical valuation average, he says. However, with over 75% of IHH's revenue from Turkey, Singapore and India's operations, the company faces FX risk given the stronger ringgit, with a 5% currency variance potentially impacting net profit by 0.3%-3.7%, he says. RHB raises IHH's target price to MYR8.80 from MYR8.00, while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR7.15.(yingxian.wong@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 29, 2024 21:28 ET (01:28 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}